🔗 Tocilizumab

Articles (8)

• Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.

  👤 Ceribelli, Angela 👤 Motta, Francesca 👤 De Santis, Maria 👤 Ansari, Aftab A 👤 Ridgway, William M 👤 Gershwin, M Eric 👤 Selmi, Carlo ⏰ 2020 📚 J Autoimmun

• A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.

  👤 Ferrey, Antoney J 👤 Choi, Grace 👤 Hanna, Ramy M 👤 Chang, Yongen 👤 Tantisattamo, Ekamol 👤 Ivaturi, Kaushik 👤 Park, Elisa 👤 Nguyen, Lawrence 👤 Wang, Brian 👤 Tonthat, Sam 👤 Rhee, Connie M 👤 Reddy, Uttam 👤 Lau, Wei Ling 👤 Huang, Susan S 👤 Gohil, Shruti 👤 Amin, Alpesh N 👤 Hsieh, Lanny 👤 Cheng, Timmy T 👤 Lee, Richard A 👤 Kalantar-Zadeh, Kamyar ⏰ 2020 📚 Am J Nephrol

• Potential therapeutic agents against COVID-19: What we know so far.

  👤 Lu, Chih-Chia 👤 Chen, Mei-Yu 👤 Chang, Yuh-Lih ⏰ 2020 📚 J Chin Med Assoc

• Tocilizumab treatment in COVID-19: a single center experience.

  👤 Luo, Pan 👤 Liu, Yi 👤 Qiu, Lin 👤 Liu, Xiulan 👤 Liu, Dong 👤 Li, Juan ⏰ 2020 📚 J Med Virol

• Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.

  👤 Xie, Mingxuan 👤 Chen, Qiong ⏰ 2020 📚 Int J Infect Dis

• The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality.

  👤 Zhang, Chi 👤 Wu, Zhao 👤 Li, Jia-Wen 👤 Zhao, Hong 👤 Wang, Gui-Qiang ⏰ 2020 📚 Int J Antimicrob Agents

• The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality.

  👤 Zhang, Chi 👤 Wu, Zhao 👤 Li, Jia-Wen 👤 Zhao, Hong 👤 Wang, Gui-Qiang ⏰ 2020 📚 Int J Antimicrob Agents

• Coronavirus disease 2019 (COVID-19): a clinical update.

  👤 Zhou, Min 👤 Zhang, Xinxin 👤 Qu, Jieming ⏰ 2020 📚 Front Med